https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Leveragen and Propeller Bio Announce Strategic Collaboration to Advance Antibody and Protein Therapeutics

Leveragen and Propeller Bio Announce Strategic Collaboration to Advance Antibody and Protein Therapeutics

BOSTON & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Leveragen, a Boston-based biotechnology company pioneering next-generation in vivo antibody discovery platforms, announced today a strategic collaboration with Propeller Bio, a newly launched biotechnology company focused on antibody and protein-based therapeutics. As part of the partnership, Propeller Bio will support the continued development of Leveragen’s antibody discovery platforms through a strategic investment. In turn, Propeller wi

administrator

Related Articles